Tanja Belcic Mikic
Overview
Explore the profile of Tanja Belcic Mikic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
23
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Belcic Mikic T, Sterle I, Maticic M, Arnol M
Biomedicines
. 2025 Feb;
13(2).
PMID: 40002884
: Since the discovery of successful direct-acting antiviral (DAA) treatment, kidneys from hepatitis C virus (HCV) RNA-positive donors represent a new opportunity to expand the organ donor pool for HCV-negative...
2.
Belcic Mikic T, Arnol M
Diagnostics (Basel)
. 2024 Nov;
14(22).
PMID: 39594148
Kidney allograft rejection is one of the main limitations to long-term kidney transplant survival. The diagnostic gold standard for detecting rejection is a kidney biopsy, an invasive procedure that can...
3.
Belcic Mikic T, Mlinsek G, Oblak M, Kandus A, Buturovic-Ponikvar J, Hawlina S, et al.
Front Med (Lausanne)
. 2023 Mar;
10:1142611.
PMID: 36999065
We present two cases of transmission of a pancreatic adenocarcinoma from a single donor to two kidney transplant recipients. Autopsy of the donor revealed a pancreatic adenocarcinoma that had already...
4.
Belcic Mikic T, Vratanar B, Pajic T, Anzej Doma S, Debeljak N, Zupan I, et al.
J Clin Med
. 2021 Dec;
10(24).
PMID: 34945099
, and mutations define clonal thrombocytosis in about 90% of patients with sustained isolated thrombocytosis. In the remainder of patients (triple-negative patients) diagnosing clonal thrombocytosis is especially difficult due to...
5.
Anzej Doma S, Drnovsek E, Kristan A, Fink M, Sever M, Podgornik H, et al.
Ann Hematol
. 2021 May;
100(8):1965-1973.
PMID: 34013406
Erythrocytosis has a diverse background. While polycythaemia vera has well defined criteria, the diagnostic approach and management of other types of erythrocytosis are more challenging. The aim of study was...
6.
Belcic Mikic T, Pajic T, Zver S, Sever M
Int J Mol Sci
. 2021 Apr;
22(7).
PMID: 33806036
mutations are a revolutionary discovery and represent an important hallmark of myeloproliferative neoplasms (MPN), especially essential thrombocythemia and primary myelofibrosis. To date, several mutations were identified, with only frameshift mutations...
7.
Belcic Mikic T, Kojc N, Frelih M, Ales-Rigler A, Veceric-Haler Z
J Clin Med
. 2021 Mar;
10(4).
PMID: 33669373
Background: Anticoagulant-related nephropathy (ARN) is a form of acute kidney injury that mainly occurs in patients with previously unrecognized glomerular disease in addition to excessive anticoagulation. Since a renal biopsy...
8.
Pajic T, Belcic Mikic T, Podgornik H, Klun J, Sucurovic S, Zver S, et al.
J Vis Exp
. 2020 Sep;
(162).
PMID: 32925885
High resolution melting analysis (HRM) is a powerful method for genotyping and genetic variation scanning. Most HRM applications depend on saturating DNA dyes that detect sequence differences, and heteroduplexes that...
9.
Belcic Mikic T, Pajic T, Sever M
Sci Rep
. 2019 Dec;
9(1):19838.
PMID: 31882869
Suspicion of myeloproliferative neoplasms (MPNs) and especially essential thrombocythemia (ET) in primary care is often based solely on blood counts, with patients referred to a haematologist without a thorough evaluation....